Macrophage-activating lipopeptide 2
Macrophage-activating lipopeptide 2 (MALP-2) is an agonist of Toll like receptors TLR-2/TLR-6. Macrophage-activating lipopeptide-2 can enhance endothelial nitric oxide synthase (eNOS) phosphorylation and endothelial cell release of NO, thereby improving vasodilation. Macrophage-activating lipopeptide-2 can enhance endothelial adhesion of white blood cells and improve perfusion recovery and collateral growth in the hind limbs of hypercholesterolemic Apoe deficient mice undergoing experimental femoral artery ligation (FAL).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 250718-44-6
- Fòrmula: C99H167N19O30S
- Peso molecular:2135.56
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
|
TLR2 |
TLR6 |
Macrophage-activating lipopeptide 2 (1 µg/mL, 24 h) can promote the expression of major endothelial adhesion molecules and leukocyte integrin receptors, thereby enhancing leukocyte endothelial adhesion[1]. Macrophage-activating lipopeptide 2 (1 µg/mL, 2 h) can promote the phosphorylation of protein kinase B and eNOS in endothelial MyEnd cells, thereby promoting NO release[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Endothelial MyEnd cells
-
Concentration:1 µg/mL
-
Incubation Time:24 h
-
Result:Caused a strong transient increase in mRNA levels of vascular cell adhesion molecule-1 (Vcam-1) after 1 hour, and also increased the levels of other major endothelial adhesion molecules, namely intercellular adhesion molecule-1 (Icam-1), E-selectin, and P-selectin, between 1-3 hours.
-
Cell Line:Endothelial MyEnd cells
-
Concentration:1 µg/mL
-
Incubation Time:2 h
-
Result:Promoted phosphorylation of protein kinase B and eNOS.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:6-10 weeks old male C57BL/6 Hypercholesterolemic Apoe-deficient mice[1].
-
Dosage:1 µg in 125 µL PBS
-
Administration:Intravenous injection (i.v.); once daily; 10 days
-
Result:Improved blood flow recovery and increased the growth of pre-existing collateral arteries in the upper and hind limbs, as well as the proliferation of endothelial cells and accumulation of peri collagenous macrophages in the collateral walls.
Chemical Information
-
No. CAS 250718-44-6
-
Peso molecular 2135.56
-
Fòrmula C99H167N19O30S
-
Synonyms
MALP-2
-
Sequence
{S-[(2R)-2,3-bis[(1-oxohexadecyl)oxy]propyl]Cys}-Gly-Asn-Asn-Asp-Glu-Ser-Asn-Ile-Ser-Phe-Lys-Glu-Lys
-
Sequence Shortening
{S-[(2R)-2,3-bis[(1-oxohexadecyl)oxy]propyl]Cys}-GNNDESNISFKEK
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)